v3.25.2
Intangible Assets Intangible Assets (Tables)
 6 Months Ended
Jun. 30, 2025
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Schedule of Finite-lived Intangible Assets
The following table presents details of the Company’s acquired intangible assets as of June 30, 2025 and December 31, 2024 (in thousands):
As of June 30, 2025Gross Carrying AmountAccumulated AmortizationNet
Finite-lived intangible assets:
Customer relationships$7,000 $(3,733)$3,267 
Trade secrets and processes5,256 (1,971)3,285 
Total intangible assets $12,256 $(5,704)$6,552 
During the six months ended June 30, 2025, the Company disposed of intangible assets related to its immersive healthcare business that had been previously impaired during the year ended December 31, 2024, resulting in the write-off of developed technology and the corresponding accumulated amortization of $83.3 million.
As of December 31, 2024Gross Carrying AmountAccumulated AmortizationNet
Finite-lived intangible assets:
Developed technology(1)
$83,289 $(83,289)$— 
Customer relationships6,192 (3,095)3,097 
Trade secrets and processes5,256 (1,840)3,416 
Total intangible assets$94,737 $(88,224)$6,513 
(1)During the year ended December 31, 2024, the Company recorded an impairment of developed technology charge of $58.9 million included within accumulated amortization in the table above. Refer to Note “4. Impairment of Immersive Healthcare Asset Group” for more information.
Finite-lived Intangible Assets Amortization Expense
The following table presents the amortization recorded related to the Company’s finite-lived intangible assets for the three and six months ended June 30, 2025 and 2024 (in thousands):
 Three Months Ended June 30,Six Months Ended June 30,
 2025202420252024
Cost of revenue$66 $66 $131 $131 
Sales, general and administrative(1)
112 2,486 218 4,974 
Total$178 $2,552 $349 $5,105 
(1)This does not include the impairment charge of $58.9 million related to the Company’s immersive healthcare developed technology during the three months ended June 30, 2024. Refer to Note “4. Impairment of Immersive Healthcare Asset Group” for more information.